← Back

$ Value

Shares

8,333

Price

Filed

Sep 3

Insider

Name

Smalling Ralph

Title

Head of Regulatory

CIK

0001983288

Roles

Officer

Transaction Details

Transaction Date

2025-09-01

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common Stock upon vesting. The RSUs will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 12 equal quarterly (every 3 months) installments thereafter. | The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter. | The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option.

Filing Info

Accession No.

0001641172-25-026396

Form Type

4

Issuer CIK

0001231457

Smalling Ralph's History

Date Ticker Type Value
2026-03-25 GNLX $602
2026-03-24 GNLX $835
2025-12-05 GNLX $774
2025-11-17 GNLX $2K
2025-09-03 GNLX $2K
2025-09-01 GNLX A $0
2025-09-01 GNLX D
2025-09-01 GNLX A
2025-08-27 GNLX A $0
2025-08-27 GNLX A $0

Other Insiders at GNLX (90d)

Insider Bought Sold Last
Yu Yong / Cappello Joseph
SVP, Clinical Development
$2K 2026-03-24
Zindrick Thomas
President and CEO
$9K 2026-03-24
Thomas John $29K 2026-03-02
Smalling Ralph
Head of Regulatory
$1K 2026-03-25